Screener
Briacell Therapeutics Corp. BCTX Q3 2025 Annual earnings
Reported October 27, 2025 · Before market open
EPS-$10.49Beat by $1.62
EPS estimate-$12.11
Next report
Date not yet announcedVersus estimates
Diluted EPS
Q2 2026-$0.99Q1 2026-$2.58Beat by $2.26Q4 2025-$4.35
Q3 2025-$10.49Beat by $1.62
Q2 2025-$16.40Beat by $1.20Q1 2025-$23.30Miss by $3.90FAQ
- When did Briacell Therapeutics Corp. report Q3 2025 earnings?
- Briacell Therapeutics Corp. (BCTX) reported Q3 2025 earnings on October 27, 2025 before market open.
- What were Briacell Therapeutics Corp.'s Q3 2025 revenue and EPS?
- Briacell Therapeutics Corp. reported eps of $-10.49 for Q3 2025.
- Did Briacell Therapeutics Corp. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-12.11 by $1.62.
- How did Briacell Therapeutics Corp.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 1340.9% from $-0.73.
- Where can I find Briacell Therapeutics Corp.'s Q3 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-25-018212) directly on SEC EDGAR. The filing index links above go to sec.gov.
